RANTUM CAPITAL INVESTS IN GETSCH+HILLER MEDIZINTECHNIK GMBH

• Getsch+Hiller is a leading German manufacturer of premium precision surgical instruments for minimally invasive and endoscopic surgery, particularly in arthroscopy, laparoscopy, spinal endoscopy, sinuscopy, urology, hysteroscopy and ENT
• Attractive growth market with long-term demographic growth drivers, rising demand for minimally invasive and endoscopic procedures, and high regulatory barriers to entry

Rantum Private Equity Fund II has acquired a stake in Getsch+Hiller Medizintechnik GmbH (“Getsch+Hiller”), headquartered in Tuttlingen-Nendingen. The company is one of Germany’s leading manufacturers of high-precision surgical instruments for minimally invasive and endoscopic surgery. Getsch+Hiller offers a broad portfolio of premium precision instruments and supplies leading international MedTech OEMs as well as distributors. The company covers the entire value chain, from development and prototyping through to high-precision manufacturing.

Founded in 2003 by Arnold Getsch and Werner Hiller, the company is based in the internationally renowned medical technology cluster around Tuttlingen and operates fully integrated production at its Nendingen site. With around 100 employees, a growing international customer base and comprehensive certifications, Getsch+Hiller has established a strong and well-entrenched market position.

The two founders and previous managing shareholders, Arnold Getsch and Werner Hiller, have successfully built and shaped the company over more than two decades. Both will remain with the company as Managing Directors and will actively shape and lead its next phase of development. The management team will be complemented by Christoph Gerber, a seasoned industry expert with many years of leadership experience in medical technology. He will focus in particular on driving the company’s strategic development and further growth.

Werner Hiller commented on the partnership: “In Rantum, we have found the right partner for the long-term future of our company and for our customers. What mattered most to us was finding an entrepreneurial, long-term-oriented partner that actively supports Getsch+Hiller’s continued growth, understands our business strategy and works with us to consistently develop it further. The partnership is the perfect foundation for a long-term strategy that offers the best possible prospects for all our employees.”

Gilles Djordjevic of Rantum Capital added: “Getsch+Hiller is a dynamic company in an attractive growth market. Its fully integrated production, long-standing customer relationships, high-quality precision products and strong positioning in high-growth segments of medical technology provide an excellent foundation for further development. We look forward to continuing this success story together with Arnold Getsch and Werner Hiller. Through targeted investments in innovation, product development and expansion into new markets, we aim to actively shape Getsch+Hiller’s next phase of growth and further expand the company’s leading market position.”

This press release is solely for the use of members of the media and should not be relied upon by personal investors, financial advisers or institutional investors.
Issued by Rantum Capital Management GmbH (reg no. HRB94787 at Maintor Panorama, Neue Mainzer Str. 2-4, 60311 Frankfurt, Germany).
Sources: Getsch+Hiller Medizintechnik, 30 June 2026